Decreased D6D reduces the levels of AA and AA-derived eicosanoids in tumor tissue. by Chengwei He (125487)

“…<p>Knocking down D6D (with RNAi) or inhibiting D6D (with selective inhibitor SC-26196) decreased (<b>a</b>) AA and (<b>b</b>) AA metabolite levels in mouse models of B16 melanoma and LLC. …”

Gene expression analysis of T3-regulated genes in the cerebral cortex of vehicle treated Wt (<i>Hr</i> n = 4; <i>Cbr2</i> n = 4; <i>Flywch2</i> n = 3; <i>Dio3</i> n = 4; <i>Abcd2</... by Soledad Bárez-López (607514)

Multivariable longitudinal analysis of short, mid and long-term prognostic factors for decreased health status as measured with the EQ-5D-3L. by Nena Kruithof (8741346)

A decrease in the amount of HBV nucleocapsids occurs when there is overexpression of singly-spliced2.2 kb RNA <i>in vivo</i>. by Yi-Ling Wang (704612)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

“…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Inhibition of PI3K activity decreases uptake of Opa_CEA-expressing gonococci via CEACAM1. by Maike Voges (154488)

RMSD graphs for the backbone of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

Cardamonin decreased the content of free fatty acids and the activity of CPT-1. by Peiguang Niu (17044532)

Decrease of bnAb activity during cell-cell transmission is variable and strain-dependent. by Lucia Reh (546554)

Cardamonin decreased the protein level of Raptor and suppressed lipogenesis and CPT-1. by Peiguang Niu (17044532)

Cre-mediated activation of RIαB allele specifically in the liver decreases PKA activity in vivo. by Brandon S. Willis (353418)

Rac1 activity rapidly decreases upon cell-cell adhesion in 3-D cell aggregates. by Khameeka N. Kitt (227731)

“…High levels of active Rac1 at 0 minutes rapidly decreased (∼66%) within 5 minutes of cell-cell adhesion, and declined to a baseline level by 30 minutes (A). …”

Decreased proliferation in tuft endothelium despite increased VEGFA level in N-CAM deficient retinas in OIR. by Joakim Håkansson (200855)

“…(A, B) Decrease in endothelial cell proliferation in N-CAM deficient retinas (B) compared to wt (A) was restricted to the tufts, whereas the remaining vasculature was unaffected (arrowheads indicate veins). …”

Complex I inhibitor decreases ROS level by Zheng Li (26302)

Effect of decreased K8 Ser 73 or Ser431 phosphorylation on migratory ability of OSCC cells. by Hunain Alam (103978)

Primary cilia frequency is decreased on both CK5+ and CK5- cancer cells. by Nadia B. Hassounah (429199)

Nicotinamide decreases BAL PMNs but causes significant hypoxemia in VILI. by Heather D. Jones (476855)

ACOT1 decreases ROS in rodent heart. by Shenglan Yang (112488)